George Magrath

Insider Reports History

Location
Farmington Hills, MI
Signature
/s/ Amy Rabourn, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Magrath:

Company Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Chief Executive Officer, Director Common Stock 1,775,293 $3,568,338 $2.01 22 Jan 2026 Direct
Opus Genetics, Inc. Chief Executive Officer, Director Warrants (right to buy) 392,157 24 Mar 2025 Direct
Opus Genetics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 330,697 13 Mar 2025 Direct

Insider Reports Filed by George Magrath

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRD Opus Genetics, Inc. 22 Jan 2026 1 $0 4 Chief Executive Officer, Director 26 Jan 2026, 19:48
IRD Opus Genetics, Inc. 01 Nov 2025 1 -$69,805 4/A Chief Executive Officer, Director 05 Nov 2025, 16:06
IRD Opus Genetics, Inc. 24 Mar 2025 2 $0 4 Chief Executive Officer, Director 26 Mar 2025, 16:10
IRD Opus Genetics, Inc. 13 Mar 2025 2 $0 4 Chief Executive Officer 17 Mar 2025, 20:53
IRD Opus Genetics, Inc. 26 Dec 2024 1 +$97,600 4 Chief Executive Officer 30 Dec 2024, 16:26
IRD Opus Genetics, Inc. 23 Dec 2024 1 $0 4 Chief Executive Officer 23 Dec 2024, 17:50
IRD Opus Genetics, Inc. 15 Nov 2024 2 +$101,158 4 Chief Executive Officer 19 Nov 2024, 16:08
IRD Opus Genetics, Inc. 01 Nov 2024 1 -$43,719 4 Chief Executive Officer 05 Nov 2024, 16:13
IRD Ocuphire Pharma, Inc. 17 May 2024 1 +$8,772 4 Chief Executive Officer 21 May 2024, 16:18
IRD Ocuphire Pharma, Inc. 18 Mar 2024 1 +$49,050 4 Chief Executive Officer 20 Mar 2024, 16:18
IRD Ocuphire Pharma, Inc. 01 Nov 2023 2 $0 4 Chief Executive Officer 03 Nov 2023, 09:29
IRD Ocuphire Pharma, Inc. 01 Nov 2023 0 $0 3 Chief Executive Officer 03 Nov 2023, 09:22